1. For policies on research and publication ethics not stated in these instructions, the Good Publication Practice Guidelines for Medical Journals, the Guidelines on Good Publication Practice, the Council of Science Editors, the International Committee of Medical Journal Editors (ICMJE), the World Association of Medical Editors (WAME), or the Korean Association of Medical Journal Editors (KAMJE) can be applied.
1) Clinical Trial Registration
Any research involving a clinical trial must be registered with a primary national clinical trial registration site accredited by the World Health Organization (WHO) or the International Committee of Medical Journal Editors (ICMJE).
2) Conflict of Interest
Authors must disclose any commercial or similar relationships with products or companies related to the submitted article. Sources of funding should be acknowledged before the reference section under the title "Conflict of Interest." Authors’ affiliations must include any corporate appointments related to the article.
3) Ethical Considerations
4) Publication Ethics
Research must adhere to the fundamental principles of honesty, truthfulness, and accuracy, and must not engage in fabrication, falsification, or plagiarism.
5) Secondary Publication
It is possible to republish manuscripts if it satisfies the condition of secondary publication of the Uniform Requirements for Manuscripts Submitted to Biomedical Journals.
All manuscripts must comply with the research and publication ethics guidelines recommended by the Korean Association of Medical Journal Editors (KAMJE) (http://kamje.or.kr/publishing_ethics.html).
1) Research Misconduct
Research must adhere to ethical standards in study design, subject selection, sample collection, and control group selection. Fabrication, falsification, and plagiarism constitute research misconduct and are strictly prohibited.
2) Ethical Approval and Consent Form
For studies involving human subjects, human-derived materials, or human medical records, authors must include one of the following statements in the Methods section: "Institutional Review Board (IRB)/Ethics Committee approval was obtained" or "IRB/Ethics Committee ruled that approval was not required for this study." If an IRB approved the study, the IRB approval number must be included in the manuscript.
3) Managing Research and Publication Misconduct
When the journal faces suspected cases of research and publication misconduct such as redundant (duplicate) publication, plagiarism, fraudulent or fabricated data, changes in authorship, an undisclosed conflict of interest, ethical problems with a submitted manuscript, a reviewer who has appropriated an author's idea or data, complaints against editors, and soon, the resolution process will follow the flowchart provided by the Committee on Publication Ethics (http://publicationethics.org/resources/flowcharts). The discussion and decision on the suspected cases are carried out by the Editorial Board.
The journal adheres to the ICMJE guidelines for authorship. Authors must meet the following four conditions:
The corresponding author is responsible for confirming that all co-authors meet these criteria. Any statement made by the corresponding author is considered representative of all co-authors.
1) PSR Definition and Roles
If a minor (under age 19) or a family member (spouse, offspring, or collateral blood relatives within the fourth degree) is included as an author, their specific roles and contributions must be explicitly stated in the manuscript.
2) Pre-Release Form Requirement
A "Pre-release Form for Co-authoring a Publication with Person with Special Relationship" must be submitted if a PSR is listed as an author.